Saturday, January 29, 2022
wellness India Expo
Home Tags Drugs

Tag: drugs

Global medicine spending to reach $1.8 trillion in 2026: IQVIA study

A total of 300 new drugs are expected to be launched over the next five years to 2026, significantly higher than levels seen on average during the past decade, and are expected to skew toward specialty, niche and orphan drugs

PLI scheme for pharma: Govt approves 42 applications, commits investment of...

In total, 215 applications were received for the domestic manufacturing of 36 products spread across the 4 target segments including critical KSMs, Drug Intermediates and APIs

Leading oncologists call for greater adoption of tech innovations to improve...

At the event organized by Oncology Forum and Fortis Cancer Institute, Delhi NCR, global experts also emphasized on the need for collaborative efforts to bring globally acclaimed treatment solutions for patients suffering from cancer

India’s pharma industry & academia join hands to catalyze innovation in...

At the first CSIR-IPA Pharma Innovation Exchange Forum, the scientists come together to stimulate industry and academia exchange on pharmaceutical innovation knowledgebase and to forge future collaborations......................

Researchers develop alternatives to curb antibiotic resistance

A new study, conducted by the scientists at Council Of Scientific And Industrial Research–Central Food Technological Research Institute (CSIR–CFTRI), has sounded alarm bell on the indiscriminate and rampant use of such 'conventional antibiotics' in the food industry....................................

Pharma PLI scheme to have export generation potential of Rs 1,96,000...

The scheme estimated to generate 20,000 direct and 80,000 indirect jobs, incentivizes the manufacturing of patented drugs and other high value drugs at an incentive rate of 10% of incremental sales..........................

COVID-19 vaccination: 26.68 crore vaccine doses provided to States/UTs

More than 1.40 crore doses still available with States/UTs to be administered.................

MTaI welcomes NPPA move to cap trade margins of oxygen concentrators

Medical Technology Association of India has stated that the #NPPA's move to cap prices of oxygen concentrations will provide reasonable margin for players, while at the same time usher in affordability for patients.......................

DCGI green signal to COVAXIN’s Phase II/III clinical trial in 2-18...

Hyderabad based Bharat Biotech to conduct clinical trials in 525 healthy volunteers........................

Cipla signs licensing deal with Lilly to expand access to COVID-19...

Baricitinib was issued a restricted emergency use approval by the CDSCO, Ministry of Health, India for use in combination with Remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in hospitalized adults..........................